colforsin has been researched along with Lung Injury, Acute in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, YH; Liu, J; Ma, L; Qiang, D; Qing, C; Xu, Y; Yang, W; Zhang, M; Zhang, Y; Zhen, C | 1 |
Hattori, Y; Oishi, H; Takano, K; Takebe, M; Tomita, K; Yamazaki, M; Yokoo, H | 1 |
2 other study(ies) available for colforsin and Lung Injury, Acute
Article | Year |
---|---|
Isoforskolin pretreatment attenuates lipopolysaccharide-induced acute lung injury in animal models.
Topics: Acute Lung Injury; Animals; Cell Adhesion; Cells, Cultured; Coleus; Colforsin; Cytokines; Disease Models, Animal; Enzyme Activation; Humans; Inflammation Mediators; Leukocytes, Mononuclear; Lipopolysaccharides; Lung; Mice; Neutrophils; Peroxidase; Rats | 2011 |
Olprinone and colforsin daropate alleviate septic lung inflammation and apoptosis through CREB-independent activation of the Akt pathway.
Topics: Acute Lung Injury; Androstadienes; Animals; Apoptosis; Cecum; Colforsin; Cyclic AMP Response Element-Binding Protein; Cytokines; Enzyme Activation; Enzyme Activators; Hypotension; Imidazoles; Ligation; Lung; Male; Mice; Mice, Inbred BALB C; NF-kappa B; Phosphatidylinositol 3-Kinases; Phosphodiesterase Inhibitors; Phosphoinositide-3 Kinase Inhibitors; Pneumonia; Proto-Oncogene Proteins c-akt; Pyridones; Shock, Septic; Signal Transduction; Wortmannin | 2012 |